ESPR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ESPREsperion Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ESPREsperion Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ESPREsperion Therapeutics, Inc.

3.19▼−0.16%· post 3.20

Mkt cap$818.6MRevenue$80MQ1 FY26Revenue$403MFY25

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

ESPREsperion Therapeutics, Inc.

LLYELI Lilly & Co

3.19▼−0.16%post 3.20

Price

1,407.25▼−0.27%post 1,416.42

$818.6M

Mkt cap

$1.3T

Q1 FY26$80M

Revenue

$24.4BQ3 FY26

FY25$403M

Revenue

$65.2BFY25

ESPR3.19▼−0.16%vsLLY1,407.25▼−0.27%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ESPR, solidLLY, dashed

Supply-chain overlap

Revenue flow

ESPR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ESPR 7

PFEPfizersupplier

—Neopharmunlistedcustomer

—Otsuka Pharmaceuticalunlistedcustomer

—Seqirus Pty Ltd (CSL Seqirus)unlistedcustomer

3 more · ESPR chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›